0.3021
price up icon3.46%   0.0101
pre-market  Pre-mercato:  .30   -0.0021   -0.70%
loading
Precedente Chiudi:
$0.292
Aprire:
$0.2912
Volume 24 ore:
809.34K
Relative Volume:
0.47
Capitalizzazione di mercato:
$13.46M
Reddito:
-
Utile/perdita netta:
$-37.75M
Rapporto P/E:
-0.093
EPS:
-3.25
Flusso di cassa netto:
$-30.91M
1 W Prestazione:
-16.96%
1M Prestazione:
+4.35%
6M Prestazione:
-86.01%
1 anno Prestazione:
-92.43%
Intervallo 1D:
Value
$0.2912
$0.3149
Intervallo di 1 settimana:
Value
$0.2899
$0.38
Portata 52W:
Value
$0.224
$4.1499

Cellectar Biosciences Inc Stock (CLRB) Company Profile

Name
Nome
Cellectar Biosciences Inc
Name
Telefono
(608) 441-8120
Name
Indirizzo
100 CAMPUS DRIVE, FLORHAM PARK, NJ
Name
Dipendente
0
Name
Cinguettio
@CellectarBio
Name
Prossima data di guadagno
2025-03-05
Name
Ultimi documenti SEC
Name
CLRB's Discussions on Twitter

Confronta CLRB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CLRB
Cellectar Biosciences Inc
0.3021 13.46M 0 -37.75M -30.91M -3.25
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
483.49 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
625.60 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
583.62 35.60B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
266.83 34.53B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
274.78 29.15B 3.81B -644.79M -669.77M -6.24

Cellectar Biosciences Inc Stock (CLRB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-05 Ripresa Ladenburg Thalmann Buy
2020-07-01 Iniziato Oppenheimer Outperform
2020-01-21 Ripresa ROTH Capital Buy
2019-09-13 Iniziato ROTH Capital Buy
2016-12-21 Iniziato Ladenburg Thalmann Buy

Cellectar Biosciences Inc Borsa (CLRB) Ultime notizie

pulisher
Mar 31, 2025

Financial Contrast: Cellectar Biosciences (NASDAQ:CLRB) versus Cyclacel Pharmaceuticals (NASDAQ:CYCC) - Defense World

Mar 31, 2025
pulisher
Mar 26, 2025

Cellectar Biosciences (NASDAQ:CLRB) Now Covered by StockNews.com - Defense World

Mar 26, 2025
pulisher
Mar 19, 2025

Cellectar Biosciences (CLRB) to Release Earnings on Wednesday - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

Is Cellectar Biosciences (CLRB) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Mar 18, 2025
pulisher
Mar 18, 2025

StockNews.com Begins Coverage on Cellectar Biosciences (NASDAQ:CLRB) - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Cellectar Biosciences Enhances CEO and COO Severance Benefits - TipRanks

Mar 17, 2025
pulisher
Mar 17, 2025

What is Roth Capital’s Estimate for CLRB FY2029 Earnings? - Defense World

Mar 17, 2025
pulisher
Mar 14, 2025

Earnings call transcript: Cellectar Biosciences Q4 2024 sees restructuring amid losses - Investing.com Australia

Mar 14, 2025
pulisher
Mar 14, 2025

Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 14, 2025
pulisher
Mar 14, 2025

Cellectar Biosciences Inc (CLRB) Q4 2024 Earnings Call Highlights: Strategic Restructuring and ... - Yahoo Finance

Mar 14, 2025
pulisher
Mar 14, 2025

Cellectar Biosciences Inc (CLRB) Q4 2024 Earnings Call Highlight - GuruFocus.com

Mar 14, 2025
pulisher
Mar 14, 2025

Cellectar Biosciences Faces Financial and Legal Turmoil Amidst Restated Earnings - TipRanks

Mar 14, 2025
pulisher
Mar 14, 2025

Cellectar Biosciences Advances Cancer Drug Pipeline - TipRanks

Mar 14, 2025
pulisher
Mar 13, 2025

Cellectar Biosciences Earnings Call: Mixed Outlook Amid Successes and Challenges - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Cellectar Biosciences Reports Financial Results for Year Ended 2024 and Provides a Corporate Update - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

Cellectar's Breakthrough: 83.6% Response Rate Puts FDA Fast Track Within Reach - StockTitan

Mar 13, 2025
pulisher
Mar 13, 2025

Cellectar Biosciences Provides Update on FDA Regulatory Path for Iopofosine I 131 in Waldenström Macroglobulinemia and Advances Phase 1 Trials for New Radioconjugates - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Cellectar Biosciences COO acquires $8,400 in stock By Investing.com - Investing.com Canada

Mar 13, 2025
pulisher
Mar 12, 2025

Cellectar Biosciences COO acquires $8,400 in stock - Investing.com India

Mar 12, 2025
pulisher
Mar 11, 2025

Cellectar Biosciences to Present at the 37th Annual Roth Conference - Quantisnow

Mar 11, 2025
pulisher
Mar 11, 2025

Cellectar Biosciences Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Cellectar Biosciences, Inc. to Present at 37th Annual Roth Conference - Nasdaq

Mar 11, 2025
pulisher
Mar 11, 2025

Cancer Treatment Breakthrough? Cellectar Biosciences Reveals Latest Progress at Major Investor Conference - StockTitan

Mar 11, 2025
pulisher
Mar 10, 2025

Before You Invest, Make Sure You Check This Cellectar Biosciences Inc (NASDAQ: CLRB) Analysis - stocksregister.com

Mar 10, 2025
pulisher
Mar 10, 2025

Cellectar Biosciences (NASDAQ:CLRB) Now Covered by Analysts at StockNews.com - Defense World

Mar 10, 2025
pulisher
Mar 08, 2025

Cellectar Biosciences (CLRB) Expected to Announce Quarterly Earnings on Thursday - Defense World

Mar 08, 2025
pulisher
Mar 05, 2025

Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Thursday, March 13, 2025 - GlobeNewswire

Mar 05, 2025
pulisher
Mar 05, 2025

Cellectar Biosciences, Inc. to Report 2024 Financial Results and Corporate Update on March 13, 2025 - Nasdaq

Mar 05, 2025
pulisher
Mar 05, 2025

When Will Cellectar Biosciences Reveal Its 2024 Financial Performance? - StockTitan

Mar 05, 2025
pulisher
Mar 02, 2025

StockNews.com Initiates Coverage on Cellectar Biosciences (NASDAQ:CLRB) - Defense World

Mar 02, 2025
pulisher
Feb 14, 2025

Cellectar Biosciences (NASDAQ:CLRB) Coverage Initiated at StockNews.com - Defense World

Feb 14, 2025
pulisher
Feb 10, 2025

CLRB’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Feb 10, 2025
pulisher
Feb 10, 2025

Prepare Yourself for Liftoff: Cellectar Biosciences Inc (CLRB) - SETE News

Feb 10, 2025
pulisher
Feb 07, 2025

SEC Form 424B3 filed by Cellectar Biosciences Inc. - Quantisnow

Feb 07, 2025
pulisher
Feb 06, 2025

A look into Cellectar Biosciences Inc (CLRB)’s deeper side - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Cellectar Biosciences to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewswire

Feb 06, 2025
pulisher
Feb 05, 2025

Cellectar Biosciences, Inc. to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025 - Nasdaq

Feb 05, 2025
pulisher
Feb 05, 2025

Cellectar Biosciences Showcases Cancer Treatment Pipeline at Major Healthcare Conference - StockTitan

Feb 05, 2025
pulisher
Feb 05, 2025

Examining Cellectar Biosciences Inc (CLRB) stock is warranted - US Post News

Feb 05, 2025
pulisher
Feb 04, 2025

Cellectar faces Nasdaq delisting over share price rule - MSN

Feb 04, 2025
pulisher
Feb 04, 2025

Market Momentum Report: Cellectar Biosciences Inc (CLRB)’s Positive Close at 0.26 - The Dwinnex

Feb 04, 2025
pulisher
Feb 03, 2025

Rosalind Advisors, Inc. Increases Stake in Cellectar Biosciences Inc - GuruFocus.com

Feb 03, 2025

Cellectar Biosciences Inc Azioni (CLRB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
Capitalizzazione:     |  Volume (24 ore):